Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abveris, Acer, Adamis, Adaptimmune, Advanced Biodesign, AGTC, Bicycle, BMS, Cansino, Dyne, Gilead, Idorsia, Intellia, Jubilant, Kiadis, Lengo, Manhattan, Merck, Nanoviricides, Nascent,, Nkarta, Neos, Neurocrine, Novavax, Oncimmune, Otonomy, Promis, Rubius, Sandoz, Skyhawk, Specifica, US Worldmeds.